Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic Cardiomyopathy
- 1 August 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Genetics
- Vol. 2 (4), 314-321
- https://doi.org/10.1161/CIRCGENETICS.109.862128
Abstract
Background— Genetic testing identifies sarcomere mutation carriers (G+) before clinical diagnosis of hypertrophic cardiomyopathy (HCM), allowing characterization of initial disease manifestations. Previous studies demonstrated that impaired relaxation develops before left ventricular hypertrophy (LVH). The precise impact of sarcomere mutations on systolic function in early and late disease is unclear. Methods and Results— Comprehensive echocardiography with strain imaging was performed on 146 genotyped individuals with mutations in 5 sarcomere genes. Contractile parameters were compared in 68 preclinical (G+/LVH−), 40 overt (G+/LVH+) subjects with HCM, and 38 mutation (−) normal control relatives. All subjects had normal left ventricular ejection fraction. In preclinical HCM, global and regional peak systolic strain (ε sys ) and longitudinal systolic strain rate were not significantly different from controls, but early diastolic mitral annular velocity (Ea) was reduced by 13%. In overt HCM, there was a significant 27% and 14% decrease in global longitudinal ε sys and systolic strain rate, respectively, compared with both preclinical HCM and controls ( P Conclusions— Sarcomere mutations have disparate initial effects on diastolic and systolic functions. Preclinical HCM is characterized by impaired relaxation but preserved systolic strain. In contrast, both diastolic and longitudinal systolic abnormalities are present in overt disease despite normal ejection fraction. We propose that diastolic dysfunction is an early consequence of sarcomere mutations, whereas systolic dysfunction results from mutations combined with subsequent pathological remodeling. Identifying mechanistic pathways triggered by these mutations may begin to reshape the clinical paradigm for treatment, based on early diagnosis and disease prevention.Keywords
This publication has 31 references indexed in Scilit:
- Evidence of Impaired Left Ventricular Systolic Function by Doppler Myocardial Imaging in Patients With Systemic Amyloidosis and No Evidence of Cardiac Involvement by Standard Two-Dimensional and Doppler EchocardiographyThe American Journal of Cardiology, 2008
- Role of Tissue Doppler and Strain Echocardiography in Current Clinical PracticeCirculation, 2007
- Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse α-cardiac myosin in the laser trap assayAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Global and Regional Myocardial Function Quantification by Two-Dimensional StrainJournal of the American College of Cardiology, 2006
- Experimental Validation of a New Ultrasound Method for the Simultaneous Assessment of Radial and Longitudinal Myocardial Deformation Independent of Insonation AngleCirculation, 2005
- Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler UltrasonographyCirculation, 2004
- Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial functionJournal of the American Society of Echocardiography, 2004
- Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardiumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.JCI Insight, 1998
- A Mouse Model of Familial Hypertrophic CardiomyopathyScience, 1996